3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Breast Neoplasms
24
Neoplasms
15
Prostatic Neoplasms
12
Lung Neoplasms
11
Uterine Cervical Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
6
Pancreatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Head and Neck Neoplasms
5
Stomach Neoplasms
4
Rectal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Basal Cell
4
Uterine Cervical Dysplasia
3
Skin Neoplasms
3
Melanoma
3
Glioma
3
Glioblastoma
3
Esophageal Neoplasms
3
Disease
3
Colorectal Neoplasms
3
Central Nervous System Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Breast Neoplasms, Male
3
Breast Carcinoma In Situ
3
Barrett Esophagus
3
Thyroid Neoplasms
2
Sarcoma
2
Precancerous Conditions
2
Oligodendroglioma
2
Interventions
ferumoxtran-10
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Therapeutics
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Pregnancy Tests
1
Manual Lymphatic Drainage
1
Magnetic Resonance Spectroscopy
1
Imagery, Psychotherapy
1
Human Papillomavirus DNA Tests
1
Geriatric Assessment
1
Exercise
1
Educational Status
1
Diffusion
1
Continuous Positive Airway Pressure
1
Colposcopy
1
Chemical Fractionation
1
Biopsy, Needle
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Urogenital Neoplasms
×
Biopsy
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled